CSPC PHARMA (01093) grants a total of 33.98 million restricted shares.

date
18:01 15/10/2026
avatar
GMT Eight
CSPC PHARMA (01093) announced that the Company has recently granted a total of 33.98 million restricted shares to 260 selected participants for nil consideration under the 2018 Share Award Scheme, subject to acceptance by the grantees and the fulfillment of certain vesting conditions and performance targets.
CSPC PHARMA (01093) announced that the Company has recently granted a total of 33.98 million restricted shares to 260 selected participants for nil consideration under the 2018 Share Award Scheme, subject to acceptance by the grantees and the fulfillment of certain vesting conditions and performance targets.